Article

Does Vitamin D Production Play a Role in Fat Malabsorption?

Boston University researchers are recruiting Chron's and gastric bypass patients on which to test a fluorescent lamp capable of producing vitamin D in the skin.

Boston University School of Medicine (BUSM) researchers have been awarded a Small Business Technology Transfer (STTR) phase 1 award to develop and test a newly designed fluorescent lamp that is capable of producing vitamin D in the skin.

Dr. Michael Holick, a professor of medicine, physiology and biophysics at BUSM and director of the General Clinical Research Unit, the Bone Health Clinic, and the Heliotherapy Light and Skin Research Center, is the principal investigator of the study. Dr. Francis Farraye, a professor of medicine at BUSM and Clinical Director in the Gastroenterology Section at Boston Medical Center, is the co-investigator.

Holick believes that exposure to this newly designed indoor portable fluorescent ultraviolet irradiation device will be a cost effective way to satisfy the vitamin D requirement for patients with fat malabsorption syndromes. The researchers have partnered with KBD Inc. on this project.

According to the Holick and Farraye, they will immediately begin recruiting patients with fat malabsorption syndromes including patients with Crohn's disease and bypass surgery to participate in the study. Study participants will receive a fluorescent light device and be taught how to use it. After the training they will take the lamp home and expose their abdomen, legs or back to the vitamin D producing lamp three times a week.

After three months, the researchers will measure their blood levels of 25-hydroxyvitamin D to determine the effectiveness of the lamp in producing vitamin D in the skin. Initial results should be available in the spring of 2011.

Source: Boston University Medical Center

Related Videos
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes of Children with Crohn’s Disease
© 2024 MJH Life Sciences

All rights reserved.